09 Feb 2015
09 Feb 2015
13 May 2014
13 May 2014
24 Sep 2013
The Carroll lab is interested in understanding how Estrogen Receptor (ER) causes gene transcription and how this contributes to breast cancer progression. We are also interested in understanding how breast cancer therapies work and what happens if they fail. We explore this using molecular, genomic and proteomic approaches, with the goal of identifying the critical determinants of tumour progression so that we can develop novel therapies that specifically target them.
The lab is currently looking to recruit a PhD student to study the relationship among the transcription factors ER and FOXA1, and drug resistence in breast cancer.